FDA Restructures its Food Resources Although there were a number of significant new regulations, the most significant food industry change in 2024

Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic Act. The clause, in part, “prohibits the FDA from approving a color additive that is ingested if it causes cancer in animals or humans when ingested,” according to the agency .

The proposed "Nutrition info box" would show customers whether products have low, medium or high levels of saturated fat, sodium and added sugars.

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,

First recommended by a Trump-appointed FDA leader, multiple administrations have collaborated to snuff out this issue that costs the country $600 billion annually.

Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with Alzheimer disease administered Leqembi.

STATEN ISLAND, N.Y. — A popular brand of cookies has been recalled across the United States for containing “life-threatening' allergens, according to the Food and Drug Administration (FDA).

Discover which popular foods will be affected by the FDA's new ban on Red No. 3, the synthetic dye that adds a vibrant pop of color to candies, cakes, and some foods you wouldn't even expect.

The Food and Drug Administration (FDA) released a sweeping proposal Wednesday to try to make cigarettes less addictive by lowering the amount of nicotine they contain, an eleventh-hour plan from

First Aid Beauty has announced the recall of 2,756 jars of its Ultra Repair Cream in the coconut vanilla scent following an issue identified by the brand.

Drug companies in the U.S. are spending $4 billion a year on TV ads touting the drug benefits with rapid-fire list of possible side effects.

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts DEI initiatives.